Johnson M A, O'Brien P Q, Park J H. "一种恩格列净杂质194的合成方法" [P]. US Patent, US 9551979 B2, 2019-11-22.
发明人周伟,罗永刚,胡光. "Method for the Synthesis of Empagliflozin impurity 194" [P]. 中国发明专利, 专利号 CN 109120120 A, 授权公告日 2021-12-08.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质194 in Pharmaceutical Formulations". Phytochemistry, 2015, 194, 8288-8298.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质194 as an Impurity". J. Pharm. Biomed. Anal., 2012, 1306, (4), 546-551.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin impurity 194 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 992, (3), 4837-4866.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 恩格列净杂质194 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2010, 1030, (9), 9049-9055.